Current concepts in the evaluation and management of erectile dysfunction.
The field of erectile dysfunction continues to evolve. Updated AUA Erectile Dysfunction Guidelines and the second Princeton Consensus Panel Guidelines, as well as updates regarding the oral PDE-5 inhibitors, are the focus of this article.
Ellsworth
Pamela
P
Brown University, Providence, RI, USA.
Kirshenbaum
Eileen M
EM
D000284:Administration, Oral; D000728:Androgens / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications / Q000175:diagnosis; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D008487:Medical History Taking; D015917:Penile Prosthesis; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D012449:Safety; D013739:Testosterone / Q000009:adverse effects / Q000172:deficiency / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use
D000728:Androgens; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D013739:Testosterone